Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionTeacher Retirement System Of Texas
Latest Disclosed Ownership10,896 shares
Latest Disclosed Value $ 323,720
Teacher Retirement System Of Texas reports 12.97% decrease in ownership of TVTX / Travere Therapeutics, Inc.

On April 30, 2026 - Teacher Retirement System Of Texas filed a 13F-HR form disclosing ownership of 10,896 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $323,720 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2026 disclosing 12,520 shares of Travere Therapeutics, Inc.. This represents a change in shares of -12.97% during the quarter. The current value of the position is $492,499 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 10,896 -1,624 -12.97 324 -32.43 0.0013
2026-01-28 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 12,520 -8,180 -39.52 478 -3.24 0.0017
2025-10-30 2025-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 20,700 -1,988 -8.76 495 47.46 0.0020
2025-08-01 2025-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 22,688 773 3.53 336 -14.54 0.0014
2025-04-28 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 21,915 -1,020 -4.45 393 0.0016
2025-02-11 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 22,935 5,730 33.30 0 0.0014
2024-11-13 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 17,205 2,143 14.23 0 0.0011
2024-08-09 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 15,062 -1,665 -9.95 0 0.0007
2024-05-06 2024-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 16,727 -274 -1.61 0 0.0008
2024-02-07 2023-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 17,001 -1,803 -9.59 0 0.0010
2023-10-31 2023-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 18,804 1,641 9.56 0 0.0011
2023-07-19 2023-06-30 13F/A-1 TRAVERE THERAPEUTICS COM 89422G107 17,163 -1,738 -9.20 0 0.0018
2023-07-17 2023-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 18,901 0 0 0.0029
2023-05-12 2023-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 18,901 2,461 14.97 0 0.0029
2023-02-13 2022-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 16,440 -1,353 -7.60 0 -100.00 0.0025
2022-11-03 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 17,793 8,934 100.85 438 103.72 0.0032
2022-08-09 2022-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 8,859 -2,473 -21.82 215 -26.37 0.0014
2022-05-09 2022-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 11,332 965 9.31 292 -9.32 0.0015
2022-02-10 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 10,367 2,037 24.45 322 59.41 0.0014
2021-11-09 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 8,330 8,330 202 0.0011
2018-05-08 2018-03-31 13F RETROPHIN COM 761299106 0 -12,169 -100.00 0 -100.00
2018-02-23 2017-12-31 13F/A-2 RETROPHIN COM 761299106 12,169 12,169 256 0.0017
2018-02-06 2017-12-31 13F RETROPHIN COM 761299106 12,169 12,169 256 0.0017
2016-11-04 2016-09-30 13F RETROPHIN COM 761299106 0 -4,434 -100.00 0 -100.00
2016-08-09 2016-06-30 13F RETROPHIN COM 761299106 4,434 449 11.27 79 46.30 0.0005
2016-05-11 2016-03-31 13F RETROPHIN COM 761299106 3,985 991 33.10 54 -6.90 0.0004
2016-02-05 2015-12-31 13F RETROPHIN COM 761299106 2,994 -863 -22.37 58 -25.64 0.0004
2015-11-04 2015-09-30 13F RETROPHIN COM 761299106 3,857 2,680 227.70 78 100.00 0.0006
2015-07-22 2015-06-30 13F RETROPHIN COM 761299106 1,177 1,177 39 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.